Contemplated private placement

SoftOx Solutions AS (the “Company” or “SoftOx” with Merkur ticker: “SOFTOX-ME”)
has retained SpareBank 1 Markets AS (the “Manager”) to advise on and effect a
private placement of up to 680,000 new shares (the “Offer Shares”) directed
towards existing and new Norwegian and international investors in order to raise
gross proceeds of approximately NOK 15 million (the “Private Placement”). 

The Company has received pre-commitments from new and existing shareholders of a
total of 400, 000 shares, or about NOK 9 million. Of total pre-commitments,
members of the Board of Directors and Management have pre-committed to 220,000
shares, or about NOK 5 million.

The Offer Shares will be offered at a fixed price of NOK 22 per share. The
subscription period will commence on Monday 17 December 2018 at 08:30 hours
(CET) and close Friday 21 December at 14:00 hours (CET). The Company may,
however, at any time resolve to close or extend the subscription period at its
own discretion and for any reason without any further notice. 

The net proceeds from the Private Placement will be used to fund the Company’s
ongoing clinical trial on first in human study of its wound cleanser solution as
well as for general corporate purposes. 

The minimum subscription and allocation amount in the Private Placement will be
the NOK equivalent of EUR 100,000, provided that the Company may, at its sole
discretion, allocate an amount below EUR 100,000 to the extent applicable
exemptions from the prospectus requirement pursuant to applicable regulations,
including the Norwegian Securities Trading Act and ancillary regulations, are
available.

The allocation will be made at the sole discretion of the Company, based on
criteria such as (but not limited to) existing ownership, sector knowledge,
perceived investor quality, timeliness of application and investment horizon.
Existing shareholders will be given priority in the event that the Private
Placement is oversubscribed. 

The  Company will announce the final number of Offer Shares subscribed for in
the Private Placement in a stock exchange announcement expected to be published
after close on 21 December 2018.

The completion of the Private Placement is subject to the adoption of the
required corporate resolutions of the Company, which will include a resolution
by the Company's extraordinary general meeting if the Private Placement exceeds
the outstanding board authorization of increasing the share capital with up to
500,000 new shares.

For further information, please contact:
Mr. Geir H. Almås, CEO, tel: +47 977 59 071, e-mail: geir.almaas@soft-ox.com